bioMérieux, Inc.
Records under this name other than patents bioMérieux, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to bioMérieux, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,503,736 | Antibodies to crosslinkers and methods for using the same Term ended Term ended Nov 12, 2019 · USPTO record | Term ended | Term ended Nov 12, 2019 | USPTO record |
| US 6,596,532 | Device for isolation and surface culture of microorganisms from bulk fluids Term ended Ended no later than Dec 12, 2017 · USPTO record | Term ended | Ended no later than Dec 12, 2017 | USPTO record |
| US 6,429,007 | Nucleic acid amplification reaction station for disposable test devices Term ended Ended no later than May 2, 2017 · USPTO record | Term ended | Ended no later than May 2, 2017 | USPTO record |
| US 6,548,631 | Macrophage derived chemokine (MDC) as an anti-viral agent for the treatment and prevention of lentivirus infection Lapsed on the fee record Ended Apr 15, 2015 · USPTO record | Lapsed on the fee record | Ended Apr 15, 2015 | USPTO record |
| US 6,465,172 | HIV Immunogenic Complexes Comprising GP120 Covalently Bound to CD4 or Concanavalin A Lapsed on the fee record Ended Oct 15, 2006 · Medium confidence | Lapsed on the fee record | Ended Oct 15, 2006 | Medium confidence |